Vaccination With Flt3L, Radiation, and Poly-ICLC

200 mg administered as an IV infusion over 30 minutes Q3W

an immune cell growth factor. CDX-301 drug product is formulated as a sterile solution intended for single-use parenteral administration. Each vial contains a nominal 2.5 mg/mL CDX-301 protein in a 1 mL volume of buffered solution composed of sodium phosphate and sodium chloride, with a pH of 7.0.

The target site will get 2 small treatments of radiation.

an immune cell activating factor. vials containing 1 ml of 2 mg/mL